Sanofi has obtained orphan drug designation in Japan for rilzabrutinib as a treatment for IgG4-related disease, a rare immune-mediated condition with limited treatment options. The designation from ...
Since the launch of BestQool, this company has always aimed to deliver the most for its customers and continuously improve its home-use products, focusing on red light therapy devices. BestQool‘s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results